Back

High-dose statin therapy is effective at preventing the development of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a meta-analy

29 August 2016 (10:12 - 10:19)
Organised by:
Congress Presentation Part of: PCI complications PCI: procedural complications ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Evangelos Oikonomou

National & Kapodistrian University of Athens, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
If something goes wrong: a detailed analysis of the full spectrum of PCI-related complications in a large-scale, prospective registry study
Doctor A. Gitt (Ludwigshafen, DE)
Abstract Slides
Presentation thumbnail
Radial artery spasm: prevalence, prevention and safety vasodilators agents in a prospective randomized meta-analysis.
Doctor P. Degrell (Luxembourg, LU)
Abstract Slides
Presentation thumbnail
Cardiac preconditioning effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable angina
Doctor K. Kagawa (Kanonji, JP)
Abstract Slides
Presentation thumbnail
The effect of remote ischemic preconditioning for myocardial injury following percutaneous coronary intervention in stable angina patients with complex coronary lesion: results of the RINC trial
Doctor K. Ejiri (Okayama, JP)
Abstract
Presentation thumbnail
Pre-procedural risk score for contrast induced-acute kidney injury development in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
Doctor S. Buratti (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
PCI complications

The Event

Event poster

ESC Congress 2016

29 August 2016 10:12 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources